Announcement
19 Jul 2024
In July 2024, the U.S. Administration for Strategic Preparedness and Response (ASPR) awarded funding to Antheia to enhance domestic manufacturing of pharmaceutical ingredients for essential medicines.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
19 Jul 2024
Revocation date:
No revocation date
On 19 July 2024, the U.S. Administration for Strategic Preparedness and Response (ASPR) awarded USD 11 million to Antheia to support U.S.-based production of pharmaceutical ingredients. ASPR did no...
See all
This state act is not part of any Thread yet.